Results 81 to 90 of about 269,235 (359)
Current Options in the Treatment of COVID-19: A Review
Risk Management and Healthcare Policy, 2020 Azadeh Teimury, Elahe Mahmoodi Khaledi Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, IranCorrespondence: Elahe Mahmoodi KhalediDepartment of Cell and Molecular Biology, Faculty of Chemistry, University of ...
Teimury A, Mahmoodi Khaledi E
doaj
Blood, 2018 Oral anticoagulants are commonly prescribed but high risk to cause adverse events. Skilled drug interaction management is essential to ensure safe and effective use of these therapies.
S. Vazquez
semanticscholar +1 more source
Biomimetic Cell Membrane‐Coated Scaffolds for Enhanced Tissue Regeneration
Advanced Materials, EarlyView.This review examines the development and use of cell membrane‐coated scaffolds in tissue engineering. Bioinspired phospholipid and glycocalyx coatings enhance anti‐fouling, anti‐thrombogenic, and selective molecular recognition properties. Native cell membrane coatings further support cell‐specific interactions, immune modulation, and reduced bacterial
Carmen Alvarez‐Lorenzo +5 more
wiley +1 more source
Europace, 2013 New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and patients will have to learn how to use these drugs effectively and safely in
H. Heidbuchel +9 more
semanticscholar +1 more source
Adjusting Cell‐Surface Interactions Through a Covalent Immobilization of Biomolecules
Advanced Materials Interfaces, EarlyView.This review presents an overview of current and emerging immobilization techniques coupled with an in‐depth investigation of the underlying mechanisms governing the activity and stability of covalently immobilized biomolecules. The aim of this study is to serve as a guide for the development of long‐lasting biomedical coatings with versatile biological
Sara Shakibania +2 more
wiley +1 more source
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
Pakistan Armed Forces Medical Journal, 2020 Objective: To assess adequacy of anticoagulation in Warfarin treated patients with atrial fibrillation Study Design: Prospective observational study.
Amer Rauf +5 more
doaj +1 more source
Advanced Materials Interfaces, EarlyView.Supported lipid bilayers coupled with multielectrode array devices offer significant promise for pathogen–host cell membrane interaction studies. This work demonstrates, for the first time, the compatibility of this platform with biological fluids, in this case whole human blood, essential for any future point‐of‐care applications; as well as its ...
Alexandra Wheeler +4 more
wiley +1 more source
Thrombophilia and Recurrent Pregnancy Loss : Is heparin still the drug of choice?
Sultan Qaboos University Medical Journal, 2014 The association between thrombophilia and recurrent pregnancy loss (RPL) has become an undisputed fact. Thorombophilia creates a hypercoaguable state which leads to arterial and/or venous thrombosis at the site of implantation or in the placental blood ...
Adel Abu-Heija
doaj
Therapeutics and Clinical Risk Management, 2015 Despite the discovery and application of many parenteral (unfractionated and low-molecular-weight heparins) and oral anticoagulant vitamin K antagonist (VKA) drugs, the prevention and treatment of venous and arterial thrombotic phenomena remain major ...
Y. Mekaj +3 more
semanticscholar +1 more source
Medicine, 2000 Abstract Anticoagulation prevents pathological clot formation (e.g. on heart valves or chambers) and stops propagation and embolization of clots already developed in veins. The type, intensity and duration of anticoagulation depend on the indication. About 1.8% of the UK population requires anticoagulation. The two main anticoagulant drugs are heparin
openaire +2 more sources